Innovative Method for Water-in-Oil Emulsion Treatment Using Atmospheric Nonthermal-Plasma Technology.

The field of plasma-liquid interactions is rapidly growing, with increasing publications across applications. While plasma's interactions with water and oil have been researched, there is a notable gap in the study of plasma-emulsion interactions and their practical applications. Investigating plasma-emulsion interactions offers a dual advantage, as demonstrated in this study, as it is applicable to both water/oil separation and emulsion stabilization processes.

Developing a facile graphitic carbon nitride (g-CN)-coated stainless steel mesh with different superhydrophilic/underwater superoleophobic and superoleophilic behavior for oil-water separation.

There is an increasing demand for the development of inexpensive and effective approaches for the oil-water separation due to the global concern in oil industries. The present study was conducted to fabricate graphitic carbon nitride/thermoplastic polyurethane (g-CN/TPU)-coated stainless steel meshes via the dip-coating method to investigate the capability of g-CN nanosheets (CN-NS) in oil-water separation. CN-NS was synthesized using the polycondensation process followed by exfoliation with Hummer's method.

Protonation states at different pH, conformational changes and impact of glycosylation in synapsin Ia.

Synapsin I (SynI) is the most abundant brain phosphoprotein present at presynaptic terminals that regulates neurotransmitter release, clustering of synaptic vesicles (SVs) at active zones, and stimulates synaptogenesis and neurite outgrowth. Earlier studies have established that SynI displays pH-dependent tethering of SVs to actin filaments and exhibits a maximum binding around neutral pH, however, the effect of pH shift from acidic to basic on the conformational stability of SynI has not been explored yet. Another important aspect of SynIa is its O-GlcNAcylation (O-GlcNac) at the Thr87 position, which is responsible for the positive regulation of synaptic plasticity linked to learning and memory in mice.

Mechanistic insights into the inhibitory activity of FDA approved ivermectin against SARS-CoV-2: old drug with new implications.

The novel corona virus (Covid-19) has become a great challenge worldwide since 2019, as no drug has been reported yet. Different clinical trials are still under way. Among them is Ivermectin (IVM), an FDA approved drug which was recently reported as a successful candidate to reduce SARS-CoV-2 viral load by inhibiting Importin-1 (IMP-1 protein which subsequently affects nuclear transport of viral proteins but its basic binding mode and inhibitory mechanism is unknown.